GlassScriptPhysician profile
Zahid Abdou
NPI 1013938208
$1,856.44
in general payments reported to CMS, 2019-2025
20 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $33.19 · 2021: $105 · 2022: $328 · 2023: $338 · 2024: $435 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,208 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.27 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $323.62 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.87 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $257.27 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $209.46 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Covidien LP | $149.68 | 2019 | |
| Abbott Laboratories | $120.55 | 2024-2025 | Freestyle Libre 3 |
| Recordati_rare_diseases_inc. | $111.40 | 2024-2025 | Isturisa, Signifor Lar |
| Dexcom, INC. | $88.67 | 2021-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $49.24 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $48.82 | 2023 | Shingrix, Arexvy |
| Insulet Corporation | $37.54 | 2023-2025 | Omnipod |
| Amarin Pharma, INC. | $33.19 | 2020 | |
| Sumitomo Pharma America, INC. | $26.58 | 2024 | Gemtesa |
| Vistapharm, INC. | $24.46 | 2021 | |
| Corcept Therapeutics | $22.49 | 2024 | Korlym |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $22.28 | 2021 | |
| Radius Health, INC. | $19.32 | 2022 | |
| Kyowa Kirin, INC. | $17.84 | 2022 | |
| Amgen INC. | $16.19 | 2024 | Tepezza |
| Boston Scientific Corporation | $13.97 | 2024 | Varithena Administration Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zahid Abdou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.